Laminin and Integrin in LAMA2-Related Congenital Muscular Dystrophy: From Disease to Therapeutics.

Saved in:
Bibliographic Details
Title: Laminin and Integrin in LAMA2-Related Congenital Muscular Dystrophy: From Disease to Therapeutics.
Authors: Barraza-Flores P; Department of Pharmacology, Reno School of Medicine, University of Nevada, Reno, NV, United States., Bates CR; Department of Pharmacology, Reno School of Medicine, University of Nevada, Reno, NV, United States., Oliveira-Santos A; Department of Pharmacology, Reno School of Medicine, University of Nevada, Reno, NV, United States., Burkin DJ; Department of Pharmacology, Reno School of Medicine, University of Nevada, Reno, NV, United States.
Source: Frontiers in molecular neuroscience [Front Mol Neurosci] 2020 Feb 11; Vol. 13, pp. 1. Date of Electronic Publication: 2020 Feb 11 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101477914 Publication Model: eCollection Cited Medium: Print ISSN: 1662-5099 (Print) Linking ISSN: 16625099 NLM ISO Abbreviation: Front Mol Neurosci Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1662-5099
DOI:10.3389/fnmol.2020.00001